Clinical Trial Update: A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of Dotarem (gadoterate meglumine) for non-coronary MR angiography has completed, sponsored by Guerbet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease

Drugs mentioned

• DOTAREM (Gadoterate meglumine)

Snippet

Sponsor: Guerbet | Conditions: Arterial Occlusive Disease | Phase 4 | Status: COMPLETED